Showing results (1-10 of 112) with videos related to
Sort By:
Pageof 12
Brain Research|August 5, 2008
Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measuresSylvia Fitting, Rosemarie M Booze, Charles F MactutusThe Journal of Pharmacology and Experimental Therapeutics|June 21, 2006
Neonatal intrahippocampal glycoprotein 120 injection: the role of dopaminergic alterations in prepulse inhibition in adult ratsSylvia Fitting, Rosemarie M Booze, Charles F MactutusNeurotoxicology|September 16, 2006
Neonatal intrahippocampal gp120 injection: an examination early in developmentSylvia Fitting, Rosemarie M Booze, Charles F MactutusCurrent HIV Research|January 24, 2015
HIV-1 proteins, Tat and gp120, target the developing dopamine systemSylvia Fitting, Rosemarie M Booze, Charles F MactutusInternational Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|March 15, 2006
Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle responseSylvia Fitting, Rosemarie M Booze, Charles F MactutusJournal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 20, 2014
HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbensRobert F Roscoe, Charles F Mactutus, Rosemarie M BoozeJournal of Neurovirology|July 22, 2017
Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disordersKristen A McLaurin, Rosemarie M Booze, Charles F MactutusJournal of Neurovirology|January 5, 2019
Diagnostic and prognostic biomarkers for HANDKristen A McLaurin, Rosemarie M Booze, Charles F MactutusScientific Reports|September 7, 2016
Progression of temporal processing deficits in the HIV-1 transgenic ratKristen A McLaurin, Rosemarie M Booze, Charles F MactutusExpert Review of Anti-Infective Therapy|March 4, 2009
The ART of HIV therapies: dopaminergic deficits and future treatments for HIV pediatric encephalopathyKaty M Webb, Charles F Mactutus, Rosemarie M BoozePageof 12